The Optimum Dose of Erenumab to Improve Quality of Life in Patients with Episodic Migraines: A Systematic Review, Meta-analysis and Network Meta-analysis. (P10-12.005)
This study examined the optimum dose of erenumab in the management of patients with episodic migraines in order to improve their quality of life.
Authors
- Mohammad Alavinia (ORCID: https://orcid.org/0000-0002-5503-9362)
- Alexander Gasser (ORCID: https://orcid.org/0000-0002-5709-3784)
- Nicholas Sequeira (ORCID: https://orcid.org/0000-0002-0263-6518)
- Julio Cesar Furlan (ORCID: https://orcid.org/0000-0002-2038-0018)
Institutions
- University Health Network (CA)
- University of Toronto (CA)
- Toronto Rehabilitation Institute (CA)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000209121
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00